Retrovirology

, 2:S153 | Cite as

Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL

  • Maria S Salvato
  • C Cameron Yin
  • Hideo Yagita
  • Toshihiro Maeda
  • Ko Okumura
  • Ilia Tikhonov
  • C David Pauza
Open Access
Oral presentation
  • 724 Downloads

Keywords

Plasma Viremia Killing Mechanism Infected Macaque Viral Immunity Chronic Progressive Disease 

Acute SIV infection of macaques is a model for human AIDS typified by high levels of plasma viremia that decline with the onset of specific viral immunity. SIV infection limits the development of viral immunity and persists to allow for the establishment of chronic progressive disease. The destruction of CD4+ and CD4- lymphocytes argues that both direct and indirect killing mechanisms contribute to the loss of cells. Although early intervention with antiretroviral drugs reduces viremia and disease, it is still unclear whether protection is due to diminished viral cytopathicity or due to blocking a host mechanism for cell killing that is triggered by the high level of viral replication. We tested the role of FasL killing of bystander lymphocytes by injecting monkeys with a humanized monoclonal anti-FasL. Treatment with anti-FasL during acute infection reduced the level of apoptosis of circulating T and B cells, peak vRNA levels were unaffected but higher antibody and CTL responses to viral proteins lead to lower set-point viremia among treated macaques. Reduced bystander killing and increased viral immunity were associated with attenuated SIV disease and a significant increase in the life span of infected macaques after transient treatment with a monoclonal antibody against FasL.

Copyright information

© The Author(s) 2005

Authors and Affiliations

  • Maria S Salvato
    • 1
  • C Cameron Yin
    • 2
    • 3
  • Hideo Yagita
    • 3
  • Toshihiro Maeda
    • 4
  • Ko Okumura
    • 4
  • Ilia Tikhonov
    • 1
  • C David Pauza
    • 1
  1. 1.Institute of Human VirologyUniversity of Maryland Biotechnology InstituteBaltimoreUSA
  2. 2.Department of PathologyUniversity of Wisconsin Medical SchoolMadisonUSA
  3. 3.Department of ImmunologyJuntendo University School of MedicineTokyoJapan
  4. 4.The Chemo-Sero Therapeutic Research Institute (Kaketsuken)KumamotoJapan

Personalised recommendations